Press Release

View printer-friendly version Back

Lantheus to Host Fourth Quarter and Full Year 2013 Conference Call on March 12, 2014 at 3:00 p.m. Eastern Time

N. Billerica, Mass., March 10, 2014 –Lantheus Medical Imaging, Inc. (Lantheus) today announced that it will host a conference call at 3:00 p.m. ET on Wednesday, March 12, 2014, to discuss its financial and operating results for the fourth quarter and full year of 2013.

To access the live conference call via telephone, please dial 1-866-202-0886 (U.S. callers) or 1-617-213-8841 (international callers) and provide passcode 51663240. A live audio webcast of the call also will be available on the homepage of the Company’s website at

A replay of the telephone conference call and audio webcast will be available from approximately 8:00 p.m. ET on March 12, 2014 through midnight on March 26, 2014. To access a replay of the conference call, dial 1-888-286-8010 (U.S. callers) or 1-617-801-6888 (international callers), and provide passcode 48386015.

About Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. is a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents. The Company provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. Lantheus’ key products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs.

Lantheus has approximately 550 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada and Australia. For more information, visit